Ryan David Lake Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ryan David Lake.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ryan David Lake. Ryan David Lake is Chief Financial Officer in Recro Pharma, Inc. ($REPH) and Senior VP, Finance & CAO in Recro Pharma, Inc. ($REPH) and Chief Financial Officer in Baudax Bio, Inc. ($BXRX).
Latest Insider Trading Transactions of Ryan David Lake
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12 2021 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 3.24 | 5,172 | 16,757 | 376,564 | 381.7 K to 376.6 K (-1.35 %) |
| Jan 20 2021 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 3.03 | 1,352 | 4,097 | 382,811 | 384.2 K to 382.8 K (-0.35 %) |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 1.30 | 60,000 | 78,000 | 60,000 | |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 1.30 | 23,077 | 30,000 | 23,077 | |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 1.30 | 26,658 | 34,655 | 69,251 | 95.9 K to 69.3 K (-27.80 %) |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 95,909 | 75.9 K to 95.9 K (+26.35 %) |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 75,909 | 70.9 K to 75.9 K (+7.05 %) |
| Jan 12 2021 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 2.99 | 12,610 | 37,704 | 384,163 | 396.8 K to 384.2 K (-3.18 %) |
| Jan 12 2021 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 396,773 | 366.8 K to 396.8 K (+8.18 %) |
| Jan 12 2021 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 200,000 | 0 | 366,773 | 166.8 K to 366.8 K (+119.92 %) |
| Jan 12 2021 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 36,000 | 0 | 166,773 | 130.8 K to 166.8 K (+27.53 %) |
| Jan 05 2021 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 3.09 | 1,210 | 3,739 | 130,773 | 132 K to 130.8 K (-0.92 %) |
| Dec 18 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 3.03 | 116,505 | 353,010 | 116,505 | |
| Dec 18 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 79,208 | 0 | 131,983 | 52.8 K to 132 K (+150.09 %) |
| Dec 09 2020 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 1.14 | 4,845 | 5,523 | 70,909 | 75.8 K to 70.9 K (-6.40 %) |
| Dec 09 2020 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 1.14 | 15,064 | 17,173 | 75,754 | 90.8 K to 75.8 K (-16.59 %) |
| Dec 09 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 2.30 | 7,611 | 17,505 | 52,775 | 60.4 K to 52.8 K (-12.60 %) |
| Feb 05 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 16.62 | 45,000 | 747,900 | 45,000 | |
| Feb 05 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 12,000 | 0 | 58,738 | 46.7 K to 58.7 K (+25.68 %) |
| Feb 05 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 16.62 | 45,000 | 747,900 | 45,000 | |
| Feb 05 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 12,000 | 0 | 58,738 | 46.7 K to 58.7 K (+25.68 %) |
| Jan 29 2020 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 8.51 | 1,725 | 14,680 | 90,818 | 92.5 K to 90.8 K (-1.86 %) |
| Jan 29 2020 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Buy | M | 0.00 | 6,000 | 0 | 92,543 | 86.5 K to 92.5 K (+6.93 %) |
| Jan 22 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 16.38 | 1,095 | 17,936 | 46,738 | 47.8 K to 46.7 K (-2.29 %) |
| Jan 03 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 17.53 | 979 | 17,162 | 47,833 | 48.8 K to 47.8 K (-2.01 %) |
| Dec 09 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 17,283 | 0 | 48,812 | 31.5 K to 48.8 K (+54.82 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 6.33 | 66,327 | 419,850 | 66,327 | |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 46,429 | 0 | 86,543 | 40.1 K to 86.5 K (+115.74 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 36,096 | 0 | 40,114 | 4 K to 40.1 K (+898.36 %) |
| Jun 07 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Jun 07 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 9.55 | 719 | 6,866 | 31,529 | 32.2 K to 31.5 K (-2.23 %) |
| Jun 07 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Buy | M | 0.00 | 2,500 | 0 | 32,248 | 29.7 K to 32.2 K (+8.40 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 7.99 | 53,859 | 430,333 | 53,859 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 7.99 | 1,880 | 15,021 | 28,155 | 30 K to 28.2 K (-6.26 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 5,750 | 0 | 30,035 | 24.3 K to 30 K (+23.68 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 11,264 | 0 | 24,285 | 13 K to 24.3 K (+86.51 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 7.41 | 979 | 7,254 | 13,021 | 14 K to 13 K (-6.99 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 7.41 | 979 | 7,254 | 13,021 | 14 K to 13 K (-6.99 %) |
| Jun 07 2018 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
| Jun 07 2018 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Buy | M | 0.00 | 2,500 | 0 | 14,000 | 11.5 K to 14 K (+21.74 %) |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 9.04 | 23,000 | 207,920 | 23,000 | |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 11,500 | 0 | 11,500 | 0 to 11.5 K |
| Jun 07 2017 | REPH | Recro Pharma, Inc. | Lake Ryan David | Senior VP, Finance ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jun 07 2017 | REPH | Recro Pharma, Inc. | Lake Ryan David | Senior VP, Finance ... | Option Exercise | A | 7.58 | 65,000 | 492,700 | 65,000 |
Page: 1